Ishimoto et al. described that a CD44 variant isoform (CD44v8–10) regulated redox status in cancer cells by stabilizing xCT, a glutamate–cystine transporter (93) whose activity promotes cystine uptake for GSH synthesis (Figure 3). This evidence concerns the gene CD44 and cancer.